413 related articles for article (PubMed ID: 26141012)
1. Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.
Zhang L; Li Z; Wan Z; Kilby A; Kilby JM; Jiang W
Vaccine; 2015 Aug; 33(36):4430-6. PubMed ID: 26141012
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.
Lee KY; Tsai MS; Kuo KC; Tsai JC; Sun HY; Cheng AC; Chang SY; Lee CH; Hung CC
Hum Vaccin Immunother; 2014; 10(12):3700-10. PubMed ID: 25483681
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination.
Bhorat AE; Madhi SA; Laudat F; Sundaraiyer V; Gurtman A; Jansen KU; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
AIDS; 2015 Jul; 29(11):1345-54. PubMed ID: 25888646
[TBL] [Abstract][Full Text] [Related]
4. Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children.
Ditse Z; Adrian PV; Kuwanda L; Madhi SA
Vaccine; 2013 Sep; 31(40):4421-7. PubMed ID: 23845819
[TBL] [Abstract][Full Text] [Related]
5. Temporal Changes in Pneumococcal Colonization in HIV-infected and HIV-uninfected Mother-Child Pairs Following Transitioning From 7-valent to 13-valent Pneumococcal Conjugate Vaccine, Soweto, South Africa.
Nzenze SA; von Gottberg A; Shiri T; van Niekerk N; de Gouveia L; Violari A; Nunes MC; Madhi SA
J Infect Dis; 2015 Oct; 212(7):1082-92. PubMed ID: 25784729
[TBL] [Abstract][Full Text] [Related]
6. B-cell development and pneumococcal immunity in vertically acquired HIV infection.
Eisen S; Hayden C; Young CJ; Gilson R; Jungmann E; Jacobsen MC; Poulsom H; Goldblatt D; Klein NJ; Baxendale HE
AIDS; 2016 Jul; 30(12):1867-76. PubMed ID: 27124901
[TBL] [Abstract][Full Text] [Related]
7. Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosis.
Hafraoui K; Moutschen M; Smet J; Mascart F; Schaaf-Lafontaine N; Fillet G
Eur J Intern Med; 2009 May; 20(3):e62-5. PubMed ID: 19393481
[TBL] [Abstract][Full Text] [Related]
8. The zwitterionic type I Streptococcus pneumoniae polysaccharide does not induce memory B cell formation in humans.
Trück J; Lazarus R; Clutterbuck EA; Bowman J; Kibwana E; Bateman EA; Pollard AJ
Immunobiology; 2013 Mar; 218(3):368-72. PubMed ID: 22704520
[TBL] [Abstract][Full Text] [Related]
9. Impact of HIV-1 Infection and Antigen Class on T Follicular Helper Cell Responses to Pneumococcal Polysaccharide-Protein Conjugate Vaccine-13.
Jha V; Nicholson LK; Gardner EM; Rahkola JT; Pratap H; Scott J; Borgeson M; Jacobelli J; Janoff EN
J Immunol; 2021 May; 206(10):2402-2411. PubMed ID: 33931485
[TBL] [Abstract][Full Text] [Related]
10. [Reactogenicity, safety, immunogenicity and prophylactic effectiveness of polysaccharide pneumococcus vaccine during immunization of HIV-infected patients].
Fel'dblium IV; Nikolenko VV; Vorob'eva NN; Ivanova ÉS; Shmagel' NG; Khafizov KM; Iurganova GA; Zverev SIa
Zh Mikrobiol Epidemiol Immunobiol; 2013; (3):52-60. PubMed ID: 24000594
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine.
Glesby MJ; Watson W; Brinson C; Greenberg RN; Lalezari JP; Skiest D; Sundaraiyer V; Natuk R; Gurtman A; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
J Infect Dis; 2015 Jul; 212(1):18-27. PubMed ID: 25395187
[TBL] [Abstract][Full Text] [Related]
12. A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy.
Hung CC; Chang SY; Su CT; Chen YY; Chang SF; Yang CY; Liu WC; Wu CH; Chang SC
HIV Med; 2010 Jan; 11(1):54-63. PubMed ID: 19659943
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific B-cell response to 13-valent pneumococcal conjugate vaccine in asplenic individuals with β-thalassemia previously immunized with 23-valent pneumococcal polysaccharide vaccine.
Papadatou I; Piperi C; Alexandraki K; Kattamis A; Theodoridou M; Spoulou V
Clin Infect Dis; 2014 Sep; 59(6):862-5. PubMed ID: 24879786
[TBL] [Abstract][Full Text] [Related]
14. Memory B Cell Divergences upon Immunization Against Streptococcus pneumoniae in HIV-1-Infected Adults.
Tsachouridou O; Skoura L; Zebekakis P; Margariti A; Metallidis S
AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1053-4. PubMed ID: 26535799
[No Abstract] [Full Text] [Related]
15. Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses.
Babb R; Chen A; Hirst TR; Kara EE; McColl SR; Ogunniyi AD; Paton JC; Alsharifi M
Clin Sci (Lond); 2016 May; 130(9):697-710. PubMed ID: 26831937
[TBL] [Abstract][Full Text] [Related]
16. 23-valent pneumococcal polysaccharide vaccine elicits hierarchical antibody and cellular responses in healthy and tuberculosis-cured elderly, and HIV-1-infected subjects.
Huang H; Qian X; Pan R; Shen L; Liang S; Wang F; Zhang P; Shen H; Chen ZW
Clin Immunol; 2018 Aug; 193():1-9. PubMed ID: 29753126
[TBL] [Abstract][Full Text] [Related]
17. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine.
Rodriguez-Barradas MC; Musher DM; Lahart C; Lacke C; Groover J; Watson D; Baughn R; Cate T; Crofoot G
J Infect Dis; 1992 Mar; 165(3):553-6. PubMed ID: 1347058
[TBL] [Abstract][Full Text] [Related]
18. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.
Thanee C; Pancharoen C; Likitnukul S; Luangwedchakarn V; Umrod P; Phasomsap C; Apornpong T; Chuanchareon T; Butterworth O; Puthanakit T
Vaccine; 2011 Aug; 29(35):5886-91. PubMed ID: 21729732
[TBL] [Abstract][Full Text] [Related]
19. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
Pletz MW; Maus U; Krug N; Welte T; Lode H
Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
